Published in Immunol Rev on January 01, 2012
In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat Med (2015) 1.62
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules. FEMS Microbiol Rev (2014) 1.05
The skin microbiome: current perspectives and future challenges. J Am Acad Dermatol (2013) 0.97
Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest (2014) 0.97
Carbohydrates and T cells: a sweet twosome. Semin Immunol (2013) 0.95
Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol (2016) 0.92
Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol Rev (2014) 0.92
Microbiota and autoimmunity. Cold Spring Harb Perspect Biol (2013) 0.89
The human IgG anti-carbohydrate repertoire exhibits a universal architecture and contains specificity for microbial attachment sites. Sci Transl Med (2015) 0.89
Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice. Arthritis Rheumatol (2016) 0.87
The interplay between microbiota and inflammation: lessons from peritonitis and sepsis. Clin Transl Immunology (2016) 0.86
Biosynthetic assembly of the Bacteroides fragilis capsular polysaccharide A precursor bactoprenyl diphosphate-linked acetamido-4-amino-6-deoxygalactopyranose. Biochemistry (2013) 0.86
Interactions between the intestinal microbiota and innate lymphoid cells. Gut Microbes (2013) 0.86
The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord (2015) 0.86
Fluorescent probes for investigation of isoprenoid configuration and size discrimination by bactoprenol-utilizing enzymes. Bioorg Med Chem (2013) 0.84
Synthesis of the tumor associative α-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant. Org Biomol Chem (2014) 0.83
Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses. Vaccines (Basel) (2016) 0.80
Protein-linked glycans in periodontal bacteria: prevalence and role at the immune interface. Front Microbiol (2013) 0.79
Neutrophil mobilization by surface-glycan altered Th17-skewing bacteria mitigates periodontal pathogen persistence and associated alveolar bone loss. PLoS One (2014) 0.79
Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS One (2014) 0.79
Isolation and Flow Cytometric Characterization of Murine Small Intestinal Lymphocytes. J Vis Exp (2016) 0.78
Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol (2013) 0.78
Evidence of Bacteroides fragilis protection from Bartonella henselae-induced damage. PLoS One (2012) 0.77
Gut commensalism, cytokines, and central nervous system demyelination. J Interferon Cytokine Res (2014) 0.77
Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells. Immunobiology (2014) 0.76
Immunogenetic control of the intestinal microbiota. Immunology (2015) 0.76
Glycomics: revealing the dynamic ecology and evolution of sugar molecules. J Proteomics (2015) 0.75
Novel Approach for Evaluation of Bacteroides fragilis Protective Role against Bartonella henselae Liver Damage in Immunocompromised Murine Model. Front Microbiol (2016) 0.75
Metabolic labeling puts the microbiome under the microscope. Nat Med (2015) 0.75
Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner. Open Biol (2017) 0.75
Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties. Cell Host Microbe (2016) 0.75
Anticancer effects of the microbiome and its products. Nat Rev Microbiol (2017) 0.75
Microbial lysate upregulates host oxytocin. Brain Behav Immun (2016) 0.75
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
The human microbiome project. Nature (2007) 28.53
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Evolution of mammals and their gut microbes. Science (2008) 21.40
Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol (1974) 20.50
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol (2008) 16.57
The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med (2009) 16.02
Hay fever, hygiene, and household size. BMJ (1989) 15.94
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Natural products as sources of new drugs over the last 25 years. J Nat Prod (2007) 13.98
The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Molecular analysis of commensal host-microbial relationships in the intestine. Science (2001) 12.04
Phenotypic and functional features of human Th17 cells. J Exp Med (2007) 11.33
Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08
Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 9.81
The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26
Microbial influences in inflammatory bowel diseases. Gastroenterology (2008) 9.20
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 8.90
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (2004) 8.68
Ten great public health achievements--United States, 1900-1999. MMWR Morb Mortal Wkly Rep (1999) 8.67
ATP drives lamina propria T(H)17 cell differentiation. Nature (2008) 8.02
Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics (2010) 7.50
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) (1971) 7.03
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Exposure to environmental microorganisms and childhood asthma. N Engl J Med (2011) 6.38
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science (2011) 6.01
CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med (2003) 6.00
Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol (2007) 5.79
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 5.10
Vaccine adjuvants: putting innate immunity to work. Immunity (2010) 5.02
The mouse gut T lymphocyte, a novel type of T cell. Nature, origin, and traffic in mice in normal and graft-versus-host conditions. J Exp Med (1978) 4.57
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev (2006) 4.40
Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. MMWR Morb Mortal Wkly Rep (2005) 4.39
Drug development from marine natural products. Nat Rev Drug Discov (2008) 4.08
The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis (1977) 3.62
Bacterial programmed cell death and multicellular behavior in bacteria. PLoS Genet (2006) 3.56
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55
Programmed death in bacteria. Microbiol Mol Biol Rev (2000) 3.49
Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol (2006) 3.48
Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett (2004) 3.43
The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol (1997) 3.33
Anaerobic infections (second of three parts). N Engl J Med (1974) 3.18
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med (1977) 2.95
Polysaccharide processing and presentation by the MHCII pathway. Cell (2004) 2.88
Structural features of polysaccharides that induce intra-abdominal abscesses. Science (1993) 2.86
Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis (2002) 2.80
CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol (2003) 2.79
Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature (2001) 2.79
Impact of vaccines universally recommended for children--United States, 1990-1998. MMWR Morb Mortal Wkly Rep (1999) 2.68
Teichoic acid from the walls of Staphylococcus aureus H. Structure of the N-acetylglucosaminyl-ribitol residues. Biochem J (1962) 2.67
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med (2006) 2.41
Reverse vaccinology: developing vaccines in the era of genomics. Immunity (2010) 2.25
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun (2006) 2.20
Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis (1997) 2.17
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol (2010) 2.02
The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem (1992) 2.00
Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol (2009) 1.99
Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry (1992) 1.98
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis (2011) 1.94
Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol (2010) 1.92
Intestinal, segmented, filamentous bacteria in a wide range of vertebrate species. Lab Anim (1993) 1.88
Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis (2003) 1.84
Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J Biol Chem (1997) 1.81
Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1. Biochemistry (1980) 1.80
Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A (2008) 1.79
Intestinal, segmented, filamentous bacteria. FEMS Microbiol Rev (1992) 1.72
Lectins as chaperones in glycoprotein folding. Curr Opin Struct Biol (1998) 1.71
Chemical structure of teichoic acid from Staphylococcus aureus, strain Copenhagen. J Biol Chem (1962) 1.68
Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A (2001) 1.64
Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med (1982) 1.62
Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J (2003) 1.61
Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A (2005) 1.57
T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. J Biol Chem (2000) 1.57
Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model. J Clin Invest (1982) 1.56
Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr (2001) 1.53
Neonatal infection induces memory impairments following an immune challenge in adulthood. Behav Neurosci (2005) 1.53
Glycoproteins: glycan presentation and protein-fold stability. Structure (1999) 1.51
Morphological and physiological characterization of germfree life. Ann N Y Acad Sci (1959) 1.50
Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol (2002) 1.50
Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr Purif (1999) 1.50
How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol (2010) 1.45
Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis. J Infect Dis (1979) 1.44
Probiotics and prebiotics in pediatrics. Pediatrics (2010) 1.44
The potential of CD4 T-cell memory. Immunology (2010) 1.40
Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. J Bacteriol (1983) 1.40
NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol (2008) 1.35
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A (2005) 14.59
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Microbial exposure during early life has persistent effects on natural killer T cell function. Science (2012) 5.90
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science (2005) 3.83
Polysaccharide processing and presentation by the MHCII pathway. Cell (2004) 2.88
CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol (2003) 2.79
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med (2011) 2.78
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med (2006) 2.41
The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol (2006) 2.31
TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe (2008) 1.98
Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol (2010) 1.92
Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A (2008) 1.79
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol (2006) 1.76
Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 1.71
Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol (2002) 1.63
Bacterial glycans: key mediators of diverse host immune responses. Cell (2006) 1.57
IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol (2008) 1.53
Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol (2002) 1.50
Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol (2005) 1.46
How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol (2010) 1.45
Glycoconjugate vaccines to prevent group B streptococcal infections. Expert Opin Biol Ther (2003) 1.42
Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol (2005) 1.35
Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci (Landmark Ed) (2010) 1.27
A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun (2007) 1.27
Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation. J Immunol (2004) 1.21
Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol (2005) 1.18
Small molecule control of virulence gene expression in Francisella tularensis. PLoS Pathog (2009) 1.17
Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology (2009) 1.17
The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol (2011) 1.16
Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol (2003) 1.14
Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology (2008) 1.14
CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med (2002) 1.11
A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry (2002) 1.11
Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci U S A (2010) 1.09
Role of T cells in abscess formation. Curr Opin Microbiol (2002) 1.08
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun (2002) 1.08
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis (2004) 1.06
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. Vaccine (2008) 1.04
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis (2003) 1.02
Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation. Infect Immun (2005) 1.02
Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J Biol Chem (2010) 0.98
Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. Glycobiology (2010) 0.98
Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest (2014) 0.97
Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci U S A (2008) 0.97
Resident commensals shaping immunity. Curr Opin Immunol (2013) 0.95
Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.95
Carbohydrates and T cells: a sweet twosome. Semin Immunol (2013) 0.95
Symbiotic commensal bacteria direct maturation of the host immune system. Curr Opin Gastroenterol (2008) 0.94
Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.92
Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis (2002) 0.92
Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin Immunol (2008) 0.92
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2013) 0.92
Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun (2013) 0.91
Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A (2005) 0.90
Coming of age: carbohydrates and immunity. Eur J Immunol (2005) 0.90
Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydr Res (2003) 0.90
Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc (2012) 0.90
Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis (2007) 0.89
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes (2015) 0.89
3-Deoxy-D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J Biol Chem (2010) 0.89
Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. J Infect Dis (2011) 0.88
Conjugate vaccines against group B Streptococcus types IV and VII. J Infect Dis (2002) 0.87
Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. MBio (2013) 0.86
Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. J Infect Dis (2011) 0.86
Regulation of T cells by gut commensal microbiota. Curr Opin Rheumatol (2011) 0.85
A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine (2013) 0.84
Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis (2002) 0.84
Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection. J Bacteriol (2010) 0.84
Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling. Vaccine (2003) 0.84
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc Natl Acad Sci U S A (2008) 0.84
Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis (2004) 0.81
The atypical lipopolysaccharide of Francisella. Carbohydr Res (2013) 0.81
Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods (2011) 0.80
Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in Salmonella infection. PLoS One (2013) 0.80
Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol (2010) 0.78
Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest (2005) 0.77
Testosterone: more than having the guts to win the Tour de France. Immunity (2013) 0.76
Traffic control at the "Gut-GALT crossroads". Cell Res (2013) 0.75